Advancements in artificial pancreas and closed-loop systems are revolutionizing diabetes care by automating glucose regulation. These systems integrate continuous glucose monitors with insulin pumps, enabling real-time adjustments based on glucose fluctuations. Hybrid closed-loop models have significantly improved glycemic control, reducing the burden of frequent insulin adjustments. Innovations in dual-hormone systems, incorporating glucagon alongside insulin, aim to further enhance stability and minimize hypoglycemia risks. While current technology continues to evolve, challenges such as sensor accuracy, accessibility, and cost remain. With ongoing development, fully automated, next-generation artificial pancreas systems are expected to provide more precise, user-friendly solutions for diabetes management.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti